Indaptus Therapeutics is trading 11.48% up at $1.36, after rising from the September 4 close of $1.22, with no confirmed company-specific catalyst identified for the September 8, 2026 move.
- The latest reported disclosure was a routine board-member resignation.
- Broader U.S. markets were lower.
- The sharp gain is not clearly explained by company news or market direction.